MedTrace Logo

Evaluation of a Virtual Reality-based Version of the Multiple Errands Test in Alcohol Use Disorder

NCT07593664 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2026-05-20

No results posted yet for this study

Summary

The goal of this study is to validate the virtual version of the Multiple Errands Test (V-MET) as a tool for assessing executive functions in patients with alcohol use disorder (AUD).

More specifically, the project aims to:

1. evaluate if the performance in the virtual version of the test is related to the performance in the original test in patients with AUD.
2. establish whether the virtual version of the test is sensitive enough to detect patients with or without an executive function deficit.

All participants will perform the original version (in a real-life supermarket) and the virtual version of the test (in a virtual reality environment).

Performance in the two versions of the test will be compared. Participants will also complete a battery of neuropsychological tests and questionnaires.

Conditions

  • Alcohol Use Disorder (AUD)

Interventions

BEHAVIORAL

Multiple Errand Test (MET)

The test takes place in a real supermarket. Participants must complete a list of tasks (e.g., purchasing certain items, collecting some information) while adhering to rules (e.g., not visiting the same place twice, etc).

BEHAVIORAL

Virtual MET

The test takes place in a virtual supermarket, developed on the C2Neuro app by C2CARE®. Participants must complete a similar list of tasks to the MET (e.g., purchasing certain items, collecting some information) and adhere to similar to rules (e.g., not visiting the same place twice, etc) .

Sponsors & Collaborators

  • Hôpital le Vinatier

    lead OTHER

Principal Investigators

  • Christophe ICARD, MD · CH Le Vinatier

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2028-06-30
Completion
2028-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07593664 on ClinicalTrials.gov